Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CLDX > SEC Filings for CLDX > Form 8-K on 13-Jun-2013All Recent SEC Filings

Show all filings for CELLDEX THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro



Submission of Matters to a Vote of Security Holders, Financial Stateme

Item 5.07. Submission of Matters to a Vote of Security Holders

At the Annual Meeting held on June 12, 2013, our stockholders voted on the four proposals listed below. The final results for the votes regarding each proposal are set forth below.

1. Our shareholders elected the following individuals to serve on our board of directors until the annual meeting of shareholders to be held in 2014. The tabulation of votes with respect to the election of such directors was as follows:

                              For       Withheld    Non-Votes
Larry Ellberger            49,795,348   1,447,550   18,254,566
Anthony S. Marucci         49,438,992   1,803,906   18,254,566
Herbert J. Conrad          49,721,261   1,521,637   18,254,566
George O. Elston           49,787,522   1,455,376   18,254,566
Harry H. Penner, Jr.       49,679,349   1,563,549   18,254,566
Timothy M. Shannon, M.D.   49,472,760   1,770,138   18,254,566
Karen L. Shoos             49,688,142   1,554,756   18,254,566

2. Our shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2013. The tabulation of votes with respect to this proposal was as follows:

   For        Against     Abstain    Non-Votes
67,305,153   1,118,025   1,074,286           -

3. Our shareholders approved the Amendment to our 2004 Plan described in Item 5.02(e) of this Current Report. The tabulation of votes with respect to this proposal was as follows:

   For       Against    Abstain    Non-Votes
49,478,058   732,652   1,032,188   18,254,566

4. Our shareholders voted to approve, on an advisory, non-binding basis, the compensation for our named executive officers. The tabulation of votes with respect to this proposal was as follows:

   For        Against     Abstain    Non-Votes
48,971,509   1,150,011   1,121,378   18,254,566

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

10.1 Celldex Therapeutics., Inc. 2004 Employee Stock Purchase Plan, as amended as of March 6, 2013

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


By: /s/ Avery W. Catlin
Name: Avery W. Catlin
Title: Senior Vice President / Chief Financial Officer

Dated: June 13, 2013

  Add CLDX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CLDX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.